KRONOS: 24-week study of triple fixed-dose combination budesonide/glycopyrronium/formoterol (BGF) MDI via co-suspension delivery technology vs glycopyrronium/formoterol (GFF) MDI, budesonide/formoterol (BFF) MDI and BFF inhalation powder in COPD
单位：[1]Pulmonary Research Institute of Southeast Michigan, Farmington Hills, United States of America[2]LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany[3]Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, United States of America[4]Sahlgrenska University Hospital, Gothenberg, Sweden[5]National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[6]Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan[7]Pearl – A member of the AstraZeneca Group, Durham, United States of America[8]Pearl – A member of the AstraZeneca Group, Morristown, United States of America[9]AstraZeneca Gothenburg, Mölndal, Sweden
第一作者单位：[1]Pulmonary Research Institute of Southeast Michigan, Farmington Hills, United States of America
推荐引用方式(GB/T 7714)：
Gary T. Ferguson,Klaus F. Rabe,Fernando J. Martinez,et al.KRONOS: 24-week study of triple fixed-dose combination budesonide/glycopyrronium/formoterol (BGF) MDI via co-suspension delivery technology vs glycopyrronium/formoterol (GFF) MDI, budesonide/formoterol (BFF) MDI and BFF inhalation powder in COPD[J].EUROPEAN RESPIRATORY JOURNAL.2018,52:doi:10.1183/13993003.congress-2018.OA1661.
APA：
Gary T. Ferguson,Klaus F. Rabe,Fernando J. Martinez,Leonardo M. Fabbri,Chen Wang...&Paul Dorinsky.(2018).KRONOS: 24-week study of triple fixed-dose combination budesonide/glycopyrronium/formoterol (BGF) MDI via co-suspension delivery technology vs glycopyrronium/formoterol (GFF) MDI, budesonide/formoterol (BFF) MDI and BFF inhalation powder in COPD.EUROPEAN RESPIRATORY JOURNAL,52,
MLA：
Gary T. Ferguson,et al."KRONOS: 24-week study of triple fixed-dose combination budesonide/glycopyrronium/formoterol (BGF) MDI via co-suspension delivery technology vs glycopyrronium/formoterol (GFF) MDI, budesonide/formoterol (BFF) MDI and BFF inhalation powder in COPD".EUROPEAN RESPIRATORY JOURNAL 52.(2018)
医学